X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (89) 89
male (70) 70
humans (60) 60
urology & nephrology (52) 52
testosterone (51) 51
animals (44) 44
metabolic syndrome (39) 39
erectile dysfunction (33) 33
endocrinology & metabolism (32) 32
rabbits (26) 26
rats (21) 21
analysis (20) 20
benign prostatic hyperplasia (20) 20
female (19) 19
inflammation (19) 19
disease models, animal (18) 18
middle aged (17) 17
men (16) 16
risk factors (16) 16
obesity (15) 15
rats, sprague-dawley (14) 14
adult (13) 13
aged (13) 13
prostate (13) 13
urology (13) 13
androgens (12) 12
expression (12) 12
gene expression (12) 12
hypogonadism (12) 12
impotence (12) 12
metabolic syndrome - complications (12) 12
piperazines - pharmacology (12) 12
tadalafil (12) 12
testosterone - blood (12) 12
cells, cultured (11) 11
quality-of-life (11) 11
sildenafil citrate (11) 11
immunohistochemistry (10) 10
late-onset hypogonadism (10) 10
lower urinary tract symptoms (10) 10
lower urinary-tract (10) 10
nitric-oxide synthase (10) 10
reverse transcriptase polymerase chain reaction (10) 10
sulfones - pharmacology (10) 10
testosterone - therapeutic use (10) 10
erectile dysfunction - drug therapy (9) 9
erectile dysfunction - etiology (9) 9
functional-activity (9) 9
pde5 (9) 9
postmenopausal women (9) 9
prostatic hyperplasia - pathology (9) 9
sexual dysfunction (9) 9
vardenafil dihydrochloride (9) 9
bph (8) 8
corpus cavernosum (8) 8
hormones (8) 8
hyperplasia (8) 8
luts (8) 8
metabolic syndrome - drug therapy (8) 8
metabolic syndrome - metabolism (8) 8
metabolic syndrome - pathology (8) 8
sexual disorders (8) 8
smooth-muscle (8) 8
chenodeoxycholic acid - analogs & derivatives (7) 7
female sexual dysfunction (7) 7
hypogonadism - drug therapy (7) 7
imidazoles - pharmacology (7) 7
medicine & public health (7) 7
messenger rna (7) 7
nitric oxide (7) 7
pde5 inhibitors (7) 7
prostate - pathology (7) 7
receptors, cytoplasmic and nuclear - agonists (7) 7
rna, messenger - metabolism (7) 7
testosterone - pharmacology (7) 7
triazines - pharmacology (7) 7
bladder (6) 6
estradiol - pharmacology (6) 6
hypertension (6) 6
hypogonadism - physiopathology (6) 6
improves erectile function (6) 6
insulin-resistance (6) 6
muscle, smooth - drug effects (6) 6
phosphodiesterase inhibitors - pharmacology (6) 6
premature ejaculation (6) 6
receptors, cytoplasmic and nuclear - metabolism (6) 6
risk-factors (6) 6
rna, messenger - genetics (6) 6
serum testosterone (6) 6
signal transduction - drug effects (6) 6
surveys and questionnaires (6) 6
urinary bladder - drug effects (6) 6
urinary-tract symptoms (6) 6
vardenafil (6) 6
women (6) 6
androgen receptor activation (5) 5
androgens - pharmacology (5) 5
andrology (5) 5
body-mass index (5) 5
cardiovascular-disease (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Urology, ISSN 1759-4812, 12/2019
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 05/2017, Volume 14, Issue 5, pp. e214 - e214
Journal Article
Journal Article
Asian journal of andrology, ISSN 1008-682X, 08/2019
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 2014, Volume 11, Issue 7, pp. 369 - 370
Journal Article
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 08/2014, Volume 11, Issue 7, pp. 369 - 370
Vignozzi, L. & Maggi, M. Nat. Rev. Urol. 11, 369-370 (2014); published online 1 July 2014; doi: 10.1038/nrurol.2014.143 
Care and treatment | Biopsy | Prostatectomy | Inflammation | Research | Diagnosis | Prostate cancer | Health aspects | Prostate
Journal Article
The Prostate, ISSN 0270-4137, 09/2013, Volume 73, Issue 13, pp. 1391 - 1402
BACKGROUND Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH)/low urinary tract symptoms (LUTS) are often comorbid. Chronic inflammation is one of... 
metabolic syndrome | lipids | tadalafil | PDE5 inhibitors | inflammation | BPH/LUTS | prostate | vardenafil | SPONTANEOUSLY HYPERTENSIVE-RATS | TESTOSTERONE | MODEL | ANDROGEN RECEPTOR ACTIVATION | BENIGN PROSTATIC HYPERPLASIA | URINARY-TRACT SYMPTOMS | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | OXYTOCIN RECEPTOR | BLADDER | CGMP-MEDIATED INHIBITION | Cyclic GMP - pharmacology | Inflammation - pathology | Sulfones - therapeutic use | Prostatic Hyperplasia - pathology | Triazines - therapeutic use | Lower Urinary Tract Symptoms - pathology | Humans | Middle Aged | Male | Sulfones - pharmacology | Prostate - metabolism | Myofibroblasts - metabolism | Prostate - pathology | Inflammation - metabolism | Cyclic GMP - analogs & derivatives | Lower Urinary Tract Symptoms - drug therapy | Inflammation - drug therapy | Aged, 80 and over | Prostate - drug effects | Interleukin-8 - secretion | Phosphodiesterase 5 Inhibitors - therapeutic use | Imidazoles - therapeutic use | Phosphodiesterase 5 Inhibitors - pharmacology | Carbolines - therapeutic use | Prostatic Hyperplasia - drug therapy | Myofibroblasts - pathology | Triazines - pharmacology | Double-Blind Method | Treatment Outcome | Imidazoles - pharmacology | Piperazines - therapeutic use | Myofibroblasts - drug effects | Piperazines - pharmacology | Prostatic Hyperplasia - metabolism | Tadalafil | Pilot Projects | Lower Urinary Tract Symptoms - metabolism | Vardenafil Dihydrochloride | Aged | Carbolines - pharmacology | Low density lipoproteins | Inflammation | Cholesterol
Journal Article
Journal Article
International Journal of Endocrinology, ISSN 1687-8337, 2014, Volume 2014, pp. 329456 - 14
Journal Article
The Prostate, ISSN 0270-4137, 06/2013, Volume 73, Issue 8, pp. 789 - 800
BACKGROUND Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH) are often comorbid. Chronic inflammation, a determinant pathogenic factor for BPH,... 
metabolic syndrome | DHT | autoimmune response | lipids | androgen | prostate, LUTS | testosterone | inflammation | BPH | LATE-ONSET HYPOGONADISM | CELL-PROLIFERATION | LUTS | HYPERPLASIA | LOWER URINARY-TRACT | INSULIN-RESISTANCE | MEN | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | UROLOGY & NEPHROLOGY | prostate | QUALITY-OF-LIFE | Prostatectomy - methods | Prostatic Hyperplasia - pathology | Humans | Middle Aged | Receptors, Androgen - metabolism | Male | Metabolic Syndrome - metabolism | Prostatitis - metabolism | Prostatitis - pathology | RNA - genetics | Metabolic Syndrome - blood | Statistics, Nonparametric | Lipoproteins, LDL - metabolism | Cytokines - genetics | Receptors, Androgen - blood | Cell Line | Cytokines - metabolism | Cholesterol, HDL - metabolism | RNA - chemistry | Reverse Transcriptase Polymerase Chain Reaction | Prostatic Hyperplasia - metabolism | Prostatic Hyperplasia - surgery | Triglycerides - metabolism | Histocytochemistry | Triglycerides - blood | Cholesterol, HDL - blood | Prostatic Hyperplasia - blood | Aged | Metabolic Syndrome - pathology | Lipoproteins, LDL - blood | Prostatitis - blood | Cohort Studies | Autoimmunity | Testosterone | Evaluation | Blood cholesterol | Analysis | Low density lipoproteins | Fibroblast growth factors | Triglycerides | Prostatitis | Inflammation | Health aspects
Journal Article